|
61. (Journal Article): Spotlight on Ethnomedicine: Usability of Sutherlandia Frutescens in the Treatment of Diabetes
Sia C ABSTRACT:
n/a
|
»
Diabetes OD
»
Disease Management
»
Metabolic Control
»
Traditional Medicine
»
Journal Article
submitted: May 04, 2007 |
|
62. (Journal Article): Large scale isolation, growth, and function of porcine neonatal islet cells.
Korbutt GS, Elliot JF, Ao Z, Smith DK, Warnock GL, Rajotte RV ABSTRACT:
Based upon existing methods of isolating fetal porcine islet tissue, a simple, reliable procedure was developed for the preparation of porcine neonatal islet cell aggregates with a...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Isolated Islet Cells
»
Journal Article
submitted: Jan 10, 2007 |
|
63. (Journal Article): Formation of insulin positive cells in implants of human pancreatic duct cell preparations from young donors.
Bogdani M, Lefebvre B, Buelens N, Bock T, Pipeleers-Marichal M, Int Veld P, Pipeleers D ABSTRACT:
AIMS/HYPOTHESIS: Pancreatic ducts are considered as potential sites for neogenesis of beta cells. In vitro studies have reported formation of islets from postnatal human and rodent...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Isolated Islet Cells
»
Ductal Cell Sources
»
Journal Article
submitted: Jan 10, 2007 |
|
64. (Journal Article): C-peptide enhances insulin-mediated cell growth and protection against high glucose induced apoptosis in SH-SY5Y cells.
Li Z-G, Zhang W, Sima AAF ABSTRACT:
BACKGROUND: We have previously reported that C-peptide exerts preventive and therapeutic effects on diabetic neuropathy in type 1 diabetic BB/Wor-rats and that it prevents duration...
|
»
Diabetes OD
»
Diabetic Complicatio...
»
Neural
»
Journal Article
submitted: Jun 13, 2006 |
|
65. (Journal Article): Formation of insulin-positive cells in implants of human pancreatic duct cell preparations from young donors.
Bogdani M, Lefebvre V, Buelens N, Bock T, Pipeleers-Marichal M, In't Veld P, Pipeleers D ABSTRACT:
AIMS/HYPOTHESIS: Pancreatic ducts are considered as potential sites for neogenesis of beta cells. In vitro studies have reported formation of islets from postnatal human and rodent...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Isolated Islet Cells
»
Ductal Cell Sources
»
Journal Article
submitted: Jan 11, 2007 |
|
66. (Journal Article): Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine.
Halban PA ABSTRACT:
Replacing missing insulin-producing beta cells to treat diabetes is a major challenge for regenerative medicine. A better understanding of beta-cell embryogenesis and regeneration ...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Other Cell Sources
»
Journal Article
submitted: Jan 11, 2007 |
|
67. (Journal Article): {alpha}L integrin I domain cyclic peptide antagonist selectively inhibits T cell adhesion to pancreatic islet microvascular endothelium
Huang M, Matthews K, Siahaan TJ, Kevil CG ABSTRACT:
Insulitis is a hallmark feature of autoimmune diabetes that ultimately results in islet beta cell destruction. We examined integrin requirements and specific inhibition of integrin...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T1DM
»
Re-establishing Tole...
»
Modifying Immunity
»
Recent Onset
»
Site-Specific Interv...
»
Journal Article
submitted: Sep 01, 2006 |
|
68. (Journal Article): Safety and hypoglycaemic properties of aqueous leaf extract of Ocimum gratissimum in streptozotocin induced diabetic rats.
Egesie UG, Adelaiye AB, Ibu JO, Egesie OJ. ABSTRACT:
The claim by Nigerian traditional herbal medicine practitioners that Ocimum gratissimum leaves has antidiabetic properties was investigated. Diabetes mellitus was induced with stre...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Complementary Therap...
»
Journal Article
submitted: Mar 30, 2007 |
|
69. (Journal Article): Diabetes mellitus: report of a WHO study group. WHO, Geneva.
World Health Organization ABSTRACT:
n/a
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T1DM
»
Journal Article
submitted: Apr 25, 2007 |
|
70. (Journal Article): Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors
Wuller S, Wiesner B, Loffler A, Furkert J, Krause G, Hermosilla R, Schaefer M, Schulein R, Rosenthal W, Oksche A ABSTRACT:
Some membrane-permeable antagonists restore cell surface expression of misfolded receptors retained in the endoplasmic reticulum (ER) and are therefore termed pharmacochaperones. W...
|
»
Diabetes OD
»
Development and Func...
»
Journal Article
submitted: Oct 15, 2009 |
|